Institut Català de la Salut
[Guala A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain. [Gil-Sala D] Vascular and Endovascular Surgery, Institut Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain. Departament de Cirurgia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Garcia Reyes ME, Allegue Allegue N, Goncalves Martins G, Constenla García I, Tello Díaz C] Servei d’Angiologia, Cirurgia Vascular i Endovascular, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Azancot MA] Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Dux-Santoy L, Garrido-Oliver J, Carrasco-Poves A, Morales-Galán A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Teixido-Turà G] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Galian-Gay L] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Evangelista A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Heart Institute, Quirónsalud-Teknon, Barcelona, Spain. [Ferreira-González I] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Center for Biomedical Research in Epidemiology and Public Health Network (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rodríguez-Palomares J] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Bellmunt Montoya S] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Cirurgia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei d’Angiologia, Cirurgia Vascular i Endovascular, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-01-24T09:37:12Z
2025-01-24T09:37:12Z
2024-11
Aorta; Aortic stiffness; Hypertension
Aorta; Rigidesa aòrtica; Hipertensió
Aorta; Rigidez aórtica; Hipertensión
Background Blunt traumatic thoracic aortic injuries (BTAIs) are associated with a high mortality rate. Thoracic endovascular aortic repair (TEVAR) is the most frequently used surgical strategy in patients with BTAI, as it offers good short- and middle-term results. Previous studies have reported an abnormally high prevalence of hypertension (HT) in these patients. This work aimed to describe the long-term prevalence of HT and provide a comprehensive evaluation of the biomechanical, clinical, and functional factors involved in HT development. Methods Twenty-six patients treated with TEVAR following BTAI with no history of HT at the time of trauma were enrolled. They were matched with 37 healthy volunteers based on age, sex, and body surface area and underwent a comprehensive follow-up study, including cardiovascular magnetic resonance, 24-hour ambulatory blood pressure monitoring, and assessment of carotid-femoral pulse wave velocity (cfPWV, a measure of aortic stiffness) and flow-mediated vasodilation. Results The mean patient age was 43.5 ± 12.9 years, and the majority were male (23 of 26; 88.5%). At a mean of 120.2 ± 69.7 months after intervention, 17 patients (65%) presented with HT, 14 (54%) had abnormal nighttime blood pressure dipping, and 6 (23%) high cfPWV. New-onset HT was related to a more proximal TEVAR landing zone and greater distal oversizing. Abnormal nighttime blood pressure was related to high cfPWV, which in turn was associated with TEVAR length and premature arterial aging. Conclusions HT frequently occurs otherwise healthy subjects undergoing TEVAR implantation after BTAI. TEVAR stiffness and length, the proximal landing zone, and distal oversizing are potentially modifiable surgical characteristics related to abnormal blood pressure.
Artículo
Versión publicada
Inglés
Avaluació de resultats (Assistència sanitària); Hipertensió; Aorta - Malalties - Mortalitat; Aorta - Ferides i lesions - Cirurgia; ANATOMY::Cardiovascular System::Blood Vessels::Arteries::Aorta::Aorta, Thoracic; Other subheadings::Other subheadings::Other subheadings::/surgery; DISEASES::Wounds and Injuries::Thoracic Injuries; Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality; DISEASES::Cardiovascular Diseases::Vascular Diseases::Hypertension; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Cardiovascular Surgical Procedures::Vascular Surgical Procedures::Endovascular Procedures; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome; ANATOMÍA::sistema cardiovascular::vasos sanguíneos::arterias::aorta::aorta torácica; Otros calificadores::Otros calificadores::Otros calificadores::/cirugía; ENFERMEDADES::heridas y lesiones::traumatismos torácicos; Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad; ENFERMEDADES::enfermedades cardiovasculares::enfermedades vasculares::hipertensión; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos cardiovasculares::procedimientos quirúrgicos vasculares::procedimientos endovasculares; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento
Elsevier
The Journal of Thoracic and Cardiovascular Surgery;168(5)
https://doi.org/10.1016/j.jtcvs.2023.07.018
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - VHIR [1655]